phosphotyrosine has been researched along with Leucocythaemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belloc, F; Chollet, C; Goldman, JM; Lagarde, V; Mahon, FX; Melo, JV; Moreau-Gaudry, F; Reiffers, J | 1 |
| Arai, A; Jin, ZH; Kurosu, T; Miura, O; Yamaguchi, M | 1 |
| Bolton, E; Mohi, MG; Morrione, A; Neel, BG; Ren, SY; Skorski, T | 1 |
| Banerji, L; Callahan, L; Catley, L; DellaGatta, JL; Fabbro, D; Griffin, JD; Hall-Meyers, E; Jiang, J; Kung, AL; Manley, PW; Mestan, J; Moreno, D; Ray, A; Weisberg, E; Wright, RD | 1 |
| Hughes, TP; Manley, PW; Quinn, SR; Saunders, VA; White, DL | 1 |
| Bertram, C; Hass, R; Schlegelberger, B; Skawran, B; Steinemann, D; von Neuhoff, N | 1 |
| Arimura, Y; Mustelin, T; Tautz, L; Vang, T; Williams, S | 1 |
| Auberger, P; Farahi Far, D; Imbert, V; Mari, B; Peyron, JF; Rossi, B | 1 |
| Garcia-Welsh, A; Laskin, DL; Laskin, JD; Molloy, CJ | 1 |
| Adunyah, SE | 1 |
| Bjorndahl, J; Lu, Y; Phillips, CA; Rodriguez, R; Trevillyan, JM | 1 |
| Hoshino, S; Inoue, S; Kanda, Y; Katada, T; Kishimoto, H; Kontani, K; Kukimonto, I | 1 |
| Hocke, GM; Nemetz, C; Piekorz, RP | 1 |
| Brizzi, MF; Dentelli, P; Ferrero, D; Lanfrancone, L; Pegoraro, L; Rosso, A | 1 |
| Chrétien, S; Fichelson, S; Gisselbrecht, S; Lacombe, C; Lecoq-Lafon, C; Mayeux, P; Verdier, F | 1 |
| Chitu, V; Demydenko, D; Hegedüs, Z; Monostori, E; Tóth, GK | 1 |
| Arimori, S; Noguchi, K; Ogawa, R; Ohtsuka, M; Sasadaira, H; Watanabe, Y | 1 |
| Ogawa, R; Ohtsuka, M; Watanabe, Y | 1 |
| Levy, J; MacDonald, I; Pawson, T | 1 |
19 other study(ies) available for phosphotyrosine and Leucocythaemia
| Article | Year |
|---|---|
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Death; Cell Division; Colony-Forming Units Assay; Cyclosporins; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Genes, MDR; Humans; Imatinib Mesylate; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphotyrosine; Piperazines; Pyrimidines; Transfection; Tumor Cells, Cultured; Verapamil | 2003 |
Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.
Topics: Animals; Apoptosis; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Cytokines; Erythropoietin; Etoposide; Flow Cytometry; G2 Phase; Glycogen Synthase Kinase 3; Humans; Interleukin-3; Leukemia; Mice; Phosphorylation; Phosphotyrosine; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt | 2005 |
Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cattle; Cell Line; Cell Transformation, Neoplastic; Fusion Proteins, bcr-abl; Humans; Leukemia; Mice; Mice, SCID; Mutation; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Protein Interaction Mapping; src Homology Domains | 2005 |
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.
Topics: Animals; Apoptosis; Benzamides; Cell Line; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia; Male; Mice; Models, Biological; Phosphotyrosine; Piperazines; Pyrimidines; Xenograft Model Antitumor Assays | 2007 |
Imatinib increases the intracellular concentration of nilotinib, which may explain the observed synergy between these drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia; Male; Mice; Models, Biological; Phosphotyrosine; Piperazines; Pyrimidines; Xenograft Model Antitumor Assays | 2007 |
The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Topics: Adenosine Triphosphatases; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Phosphotyrosine; RNA Interference; RNA, Messenger; RNA, Small Interfering; Subcellular Fractions; Tetradecanoylphorbol Acetate; Transfection; U937 Cells; Valosin Containing Protein | 2008 |
TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.
Topics: Animals; CSK Tyrosine-Protein Kinase; Down-Regulation; Gene Expression Regulation, Enzymologic; Humans; Immunologic Memory; Jurkat Cells; Leukemia; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Membrane Microdomains; Mice; Mice, Inbred C57BL; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 12; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Antigen, T-Cell; RNA, Messenger; Signal Transduction; src-Family Kinases; T-Lymphocytes; Transcriptional Activation | 2008 |
Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases.
Topics: Base Sequence; Calcium; Genes, fos; Humans; Interleukin-2; Kinetics; Leukemia; Leukocyte Common Antigens; Lymphocyte Activation; Molecular Sequence Data; NF-kappa B; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, Interleukin-2; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Tumor Cells, Cultured; Type C Phospholipases; Tyrosine; Vanadates | 1994 |
Alterations in expression of p56lck during myeloid differentiation of LSTRA cells.
Topics: Antigens, Differentiation; Bucladesine; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Cycle; Cell Differentiation; Cholecalciferol; Enzyme Induction; Granulocytes; Hematopoietic Stem Cells; Histocompatibility Antigens Class II; Humans; Leukemia; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine | 1994 |
Granulocyte-macrophage colony stimulating factor stimulates rapid phosphorylation of proteins on tyrosines in human U937 and HL-60 leukemic cells.
Topics: Blotting, Western; Cells, Cultured; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kinetics; Leukemia; Leukemia, Promyelocytic, Acute; Macrophage Colony-Stimulating Factor; Molecular Weight; Monocytes; Neoplasm Proteins; Phosphoproteins; Phosphorylation; Phosphotyrosine; Recombinant Proteins; Tumor Cells, Cultured; Tyrosine | 1993 |
CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Topics: Amino Acid Sequence; Androstadienes; Benzoquinones; Calcium; CD28 Antigens; Cytotoxicity, Immunologic; Enzyme Inhibitors; Humans; Immunity, Cellular; Lactams, Macrocyclic; Leukemia; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Molecular Sequence Data; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Quinones; Rifabutin; Signal Transduction; src-Family Kinases; Tumor Cells, Cultured; Wortmannin | 1996 |
Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bucladesine; Cell Differentiation; Cell Line; HL-60 Cells; Humans; Kinetics; Leukemia; Membrane Glycoproteins; N-Glycosyl Hydrolases; NAD+ Nucleosidase; Phosphoproteins; Phosphorylation; Phosphotyrosine; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1996 |
Members of the family of IL-6-type cytokines activate Stat5a in various cell types.
Topics: Animals; Carcinoma, Hepatocellular; DNA; DNA-Binding Proteins; Gene Expression Regulation; Growth Inhibitors; Humans; Interleukin-6; Leukemia; Leukemia Inhibitory Factor; Liver Neoplasms; Lymphokines; Mice; Milk Proteins; Phosphotyrosine; Protein Binding; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; GRB2 Adaptor Protein; Humans; Immunosorbent Techniques; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Nuclear Proteins; Phosphorylation; Phosphotyrosine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; src Homology Domains; Subcellular Fractions; Ubiquitin-Protein Ligases | 1998 |
Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Erythropoietin; Fetal Blood; Hematopoietic Stem Cells; Humans; Intracellular Signaling Peptides and Proteins; Leukemia; Molecular Weight; Phosphatidylinositol 3-Kinases; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Proteins; Recombinant Proteins; SH2 Domain-Containing Protein Tyrosine Phosphatases; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; src Homology Domains; Transfection; Tumor Cells, Cultured | 1999 |
Conditions for permeabilization of cells used for intracellular tyrosine phosphorylation studies.
Topics: Adenosine Triphosphate; Bacterial Proteins; Cations, Divalent; Cell Membrane Permeability; Digitonin; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Indicators and Reagents; Leukemia; Lysophosphatidylcholines; Phosphorylation; Phosphotyrosine; Receptors, Antigen, T-Cell; Streptolysins; Tumor Cells, Cultured | 1999 |
Immunofluorescent staining of human leukemic cells with monoclonal antibody to phosphotyrosine.
Topics: Antibodies, Monoclonal; Bone Marrow Cells; Cell Line; Fluorescent Antibody Technique; Humans; Leukemia; Phosphotyrosine; Tyrosine | 1985 |
Complement-mediated lysis of K562 human leukemic cells by antibodies to phosphotyrosine and identification of cell surface proteins phosphorylated on tyrosine.
Topics: Antibodies, Monoclonal; Cell Line; Cell Membrane; Complement System Proteins; Cytotoxicity, Immunologic; Fluorescent Antibody Technique; Humans; Leukemia; Membrane Proteins; Molecular Weight; Neoplasm Proteins; Phosphoproteins; Phosphotyrosine; Tyrosine | 1986 |
Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.
Topics: Animals; Bone Marrow; Cell Line; Gene Expression Regulation; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukemia; Mice; Molecular Weight; Peptide Fragments; Phosphoproteins; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Tyrosine | 1985 |